ANASTELLIN, THE ANGIOSTATIC FIBRONECTIN PEPTIDE, IS A SELECTIVE INHIBITOR OF LYSOPHOSPHOLIPID SIGNALING

Por Ambesi, Anthony, McKeown-Longo, Paula J.
Publicado em 2009

Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling

Por Ambesi, Anthony, McKeown-Longo, Paula J.
Publicado em 2014

Quantification of fibronectin matrix assembly sites using a novel ELISA assay

Por Zheng, Mingzhe, Ambesi, Anthony, Yu, Lin, McKeown-Longo, Paula J.
Publicado em 2006

Cryptic activity within the Type III(1) domain of fibronectin regulates tissue inflammation and angiogenesis

Por Cho, Christina, Kelsh-Lasher, Rhiannon, Ambesi, Anthony, McKeown-Longo, Paula J.
Publicado no Curr Top Pept Protein Res (2015)

Endostatin and anastellin inhibit distinct aspects of the angiogenic process

Por Pumiglia Kevin M, Ambesi Anthony, Neskey David M, McKeown-Longo Paula J
Publicado em 2008-11-01

Endostatin and anastellin inhibit distinct aspects of the angiogenic process

Por Neskey, David M, Ambesi, Anthony, Pumiglia, Kevin M, McKeown-Longo, Paula J
Publicado em 2008

TLR4 Ligands Selectively Synergize to Induce Expression of IL-8

Por Valenty, Lauren M., Longo, Christine M., Horzempa, Carol, Ambesi, Anthony, McKeown-Longo, Paula J.
Publicado no Adv Wound Care (New Rochelle) (2017)